Iraqi FM: Iran Can't Strike Israel, Yet Targets Friendly Ally

Iraqi Foreign Minister Fuad Hussein
Iraqi Foreign Minister Fuad Hussein
TT

Iraqi FM: Iran Can't Strike Israel, Yet Targets Friendly Ally

Iraqi Foreign Minister Fuad Hussein
Iraqi Foreign Minister Fuad Hussein

Hours before Iraq lodged a complaint against Iran at the UN Security Council, Foreign Minister Fuad Hussein criticized Iran’s attack on Erbil, calling it an “attempt to export its internal problems.”
Speaking to Asharq Al-Awsat on the sidelines of the World Economic Forum in Davos, Hussein stated that Iraq has taken political and diplomatic steps in response to Iran’s attack in Erbil, denying Tehran’s claims about Israeli intelligence on Iraqi soil.
Tehran’s assault had killed four civilians in Erbil on Monday.
Hussein linked the attack on Iraqi Kurdistan to rising tensions between Iran and Israel due to the Gaza conflict, suggesting clashes between Iranians and Israelis.
When asked about additional measures Iraq is considering in response to the targeting of the Iranian Revolutionary Guard in the Kurdistan region of Iraq, Hussein said: “Iraq is responding to Iran’s aggression with diplomatic, political, and legal measures.”
“We've summoned the second-in-command at the Iranian embassy, delivering a protest note about the attack in Erbil and the loss of Iraqi lives.”
“We've asked our ambassador in Tehran to return, and a joint investigation committee has been formed at the directive of the Prime Minister, set to report its findings on Wednesday.”
“Apart from these steps, we've filed a complaint with the UN Security Council.”

As for Iran's claim about targeting an Israeli Mossad headquarters in Erbil, Hussein affirmed that there’s no evidence of Israeli intelligence on Iraqi soil.
“The Iranians are deflecting internal issues onto others. Similar false accusations were made a year ago when Iran targeted a residential house, falsely claiming it was a Mossad base,” he said.
Noting that Iran seems unable to confront Israel directly, Hussein pointed to Tehran choosing to target Erbil instead.
The top Iraqi diplomat also mentioned that even with Iranian presence in Syria and on the Israeli border, Tehran appears unwilling to directly confront Israel.
Regarding the motive behind attacking Erbil, Hussein said that the whole assault is perplexing since Erbil is part of Iraq, a neighboring and friendly nation with strong historical, geographical, religious, cultural, and economic ties to Iran.
“In the past, Iraq supported Iran diplomatically, working to improve its relations with Arab and European countries and the US,” reminded Hussein.
“Now, Iran's attack on Iraq, its ally, is a strategic mistake that will likely be realized over time,” he added.
“It seems there are understood rules of engagement between Israelis and Iranians,” highlighted Hussein.
“The attack on Erbil might be viewed by some in Tehran as a response to the Kerman terrorist incident claimed by ISIS Khorasan.”
“Iran claims to fight Israelis, suggesting there are rules of engagement, but for domestic reasons, Iranians targeted the militarily weaker link, Iraq, their friend, rather than confronting their enemy directly,” noted Hussein.
In relation to the withdrawal of US forces from Iraq, Hussein mentioned that Iraq aims for a negotiation process with the US, noting Washington’s readiness for talks under normal circumstances.
“The Iraqi government insists on resolving the issue through talks, not force,” he affirmed, adding that Iraq is in ongoing discussions with the US about starting these negotiations.
“Despite recent violence, the Americans are open to discussing their presence in Iraq under normal conditions,” asserted the minister.
“We invited them in the past, and we can now ask them to leave, but it should be a mutual decision,” he explained, noting that Iraq is working towards an agreement to kickstart negotiations.
Recent weeks saw increased hostilities against US interests in Iraq, leading to Washington targeting Iraqi factions with ties to Iran.
On Iraq-Saudi relations, Hussein mentioned they are in excellent shape, expressing Iraq’s desire to boost economic cooperation and encourage Saudi investment in the country.
“Iraq and Saudi Arabia currently enjoy excellent political relations,” said Hussein.
“We've played a key role in mending ties between Saudi Arabia and Iran, and this is something we're pleased about. Iran is a neighbor, and better relations between Arab countries and Iran benefit Iraq,” he added.
Hussein further explained that tensions in the region negatively affect Iraq, so positive relations are crucial.
“Our relationship with Saudi Arabia is exceptional,” he affirmed.
As for Baghdad and Riyadh working on ways to collaborate in trade and the economy, Hussein said: “We consistently work together on oil issues within OPEC, coordinate internationally, and engage within the Arab League.”
“Looking ahead, we aim to strengthen economic ties and attract Saudi investment in Iraq. Foreign investment is vital for building Iraq's economy,” said Hussein.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.